Company Filing History:
Years Active: 2022-2025
Title: Katy Louise Everett: Innovator in Cancer Therapy
Introduction
Katy Louise Everett is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of biomedical research, particularly in the development of innovative therapies for cancer and infectious diseases. With a total of 4 patents to her name, her work is paving the way for new treatment options.
Latest Patents
Among her latest patents is the invention of Fc binding fragments comprising an OX40 antigen-binding site. This application relates to specific binding members that target OX40, which can be utilized in the treatment of various cancers and infectious diseases. Another notable patent involves LAG-3 binding members, which are designed to bind to lymphocyte-activation gene 3 (LAG-3). These specific binding members are particularly useful in cancer therapy, showcasing her commitment to advancing medical science.
Career Highlights
Katy has worked with notable companies such as F-star Therapeutics, Inc. and Invox Pharma Limited. Her experience in these organizations has allowed her to collaborate on groundbreaking projects that aim to improve patient outcomes through innovative therapies.
Collaborations
Katy has collaborated with talented individuals in her field, including Mihriban Tuna and Miguel Gaspar. These partnerships have further enhanced her research and development efforts, contributing to her success as an inventor.
Conclusion
Katy Louise Everett is a trailblazer in the realm of biomedical innovation, with a focus on cancer therapy. Her patents and collaborations reflect her dedication to improving healthcare through scientific advancements.